For subscribers
Ketamine approved in S'pore for treatment of major depressive disorder
Sign up now: Get ST's newsletters delivered to your inbox
Separately, a clinical trial is underway to test the effectiveness of oral ketamine to alleviate symptoms of treatment-resistant depression.
PHOTO: ST FILE
SINGAPORE - Ketamine, a controlled substance referred to as a party drug by those who abuse it, is now being used in authorised clinical settings in Singapore to treat patients with major depressive disorder (MDD) who are not responding well to other forms of treatment.
Esketamine has been approved by the authorities and used to treat two patients in Singapore. The modified version of ketamine is being administered via a nasal spray.
